1 completed, 1 recruiting, 1 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Cancers: new trials by email Literature Review of Cancers trials Research Report on Cancers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Pharmacokinetics of NM6603 in Chinese Patients With Advanced Solid Tumors NM6603 - Cancers | Phase 1 | Recruiting | NucMito Pharmaceuticals Co. Ltd. | 30 | 2025-12-18 | 2026-01-14 |
| A Phase 1 Study of NM6603 in Advanced Solid Tumors NM6603 - Cancers | Phase 1 | Terminated | NucMito Pharmaceuticals Co. Ltd. | 17 | 2023-08-31 | 2026-05-07 |
| Animal Assisted Therapy in a Pediatric Setting Animal Assisted Therapy - Developmental Delays, Global Developmental Delay | Phase 1 / Phase 2 | Completed | Children's Hospitals and Clinics of Minnesota | 30 | 2011-01-01 | 2014-02-14 |
Neoplasms (3) · Feeding and Eating Disorders (1) · Learning Disabilities (1) · Mental Disorders (1) · Stroke (1)
Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Communication Disorders (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurodevelopmental Disorders (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1) · Vascular Diseases (1)
NucMito Pharmaceuticals Co. Ltd. (2) · Children's Hospitals and Clinics of Minnesota (1)
United States (2) · China (1)